Climate Change Climate Change Climate Change

Alzheimer’s cases to triple by 2050–study


09:11 AM February 7th, 2013

February 7th, 2013 09:11 AM

This undated file image provided by Merck & Co., shows a cross section of a normal brain, right, and one of a brain damaged by advanced Alzheimer’s disease. A dramatic shift is beginning in the disappointing struggle to find something to slow the damage of Alzheimer’s disease: The first U.S. experiments with “brain pacemakers” for Alzheimer’s are getting under way. Scientists are looking beyond drugs to implants in the hunt for much-needed new treatments. AP/Merck & Co.

WASHINGTON – Alzheimer’s disease cases in the US will nearly triple in the next 40 years, according to new projections Wednesday that suggest there will be nearly 14 million sufferers by 2050.

In 2010, there were just 4.7 million people with Alzheimer’s disease in the United States.

The researchers who made the projections attribute the predicted increase to the high numbers of “baby boomers” — the especially large generation born after World War II — who are now reaching old age.

More than half of those with the disease by 2050, some seven million people, will be 85 or older, the researchers said.

The trend has been noted in the past, but the new study updates the figures, and highlights the need for doctors and others to get in gear in anticipation, said co-author Jennifer Weuve, from the Rush University Medical Center in Chicago.

The high numbers of Alzheimer’s sufferers “will place a huge burden on society, disabling more people who develop the disease, challenging their caregivers, and straining medical and social safety nets,” Weuve explained.

“Our study draws attention to an urgent need for more research, treatments and preventive strategies to reduce this epidemic,” she added.

For the study, the authors analyzed nearly two decades of data from 10,802 African Americans and whites, aged 65 and older, living in Chicago.

Every three years from 1993 to 2011, the study participants were interviewed and assessed for dementia, while taking into account age, race, and educational level.

The researchers also factored in US death rates, education, and current and future population estimates from the US census bureau.

Disclaimer: Comments do not represent the views of We reserve the right to exclude comments which are inconsistent with our editorial standards. FULL DISCLAIMER

For feedback, complaints, or inquiries, contact us.